848307-24-4

Basic information

• Product Name: ((3R,4S)-4-PHENYLPYRROLIDIN-3-YL)METHANOL
• Synonyms: ((3R,4S)-4-PHENYLPYRROLIDIN-3-YL)METHANOL
• CAS NO: 848307-24-4
• Molecular Formula: C₁₁H₁₅NO
• Molecular Weight: 177.24
• Mol File: 848307-24-4.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 316.1 °C at 760 mmHg
• Flash Point: 135.7 °C
• Appearance: /
• Density: 1.058 g/cm³
• Vapor Pressure: 0.000177mmHg at 25°C
• Refractive Index: 1.538
• PKA: 14.93±0.10(Predicted)
• CAS DataBase Reference: ((3R,4S)-4-PHENYLPYRROLIDIN-3-YL)METHANOL(CAS DataBase Reference)
• NIST Chemistry Reference: ((3R,4S)-4-PHENYLPYRROLIDIN-3-YL)METHANOL(848307-24-4)
• EPA Substance Registry System: ((3R,4S)-4-PHENYLPYRROLIDIN-3-YL)METHANOL(848307-24-4)

Safety Data

• Hazardous Substances Data: 848307-24-4(Hazardous Substances Data)

Usage

General Description

((3R,4S)-4-Phenylpyrrolidin-3-yl)methanol is a chemical compound with a structure consisting of a 3R, 4S configuration, a phenyl group, and a pyrrolidinyl ring. It is a chiral compound, meaning it has a non-superimposable mirror image. This chemical has potential applications in the field of medicinal chemistry, as it can be used as a precursor for the synthesis of various pharmaceuticals. Additionally, it may have uses in academic research, particularly in the study of organic chemistry and drug design. Due to its specific structure and properties, (3R,4S)-4-Phenylpyrrolidin-3-yl)methanol has the potential to contribute to the development of new drugs and therapeutic agents.

InChI:InChI=1/C11H15NO/c13-8-10-6-12-7-11(10)9-4-2-1-3-5-9/h1-5,10-13H,6-8H2/t10-,11-/m1/s1

Upstream product

• 221141-87-3 [(3R,4S)-1-benzyl-4-phenylpyrrolidin-3-yl]methanol 
• 848307-25-5 (3R,4S)-tert-butyl 3-(hydroxymethyl)-4-phenylpyrrolidine-1-carboxylate 
• 5153-67-3 nitrostyrene 

Downstream Products

• 848307-25-5 (3R,4S)-tert-butyl 3-(hydroxymethyl)-4-phenylpyrrolidine-1-carboxylate 

Relevant articles and documents

Antinociceptive and antidepressant-like action of endomorphin-2 analogs with proline surrogates in position 2

In our efforts to develop new candidate drugs with antinociceptive and/or antidepressant-like activity, two novel endomorphin-2 (EM-2, Tyr-Pro-Phe-Phe-NH2) analogs, containing proline surrogates in position 2 were synthesized using commercially

NOVEL SPIROTROPANE COMPOUNDS AND METHODS FOR THE MODULATION OF CHEMOKINE RECEPTOR ACTIVITY

Compounds according to formula (I): wherein the radical R2 represents a hydrogen atom or one of the following structures: R, and R7_9are as herein defined, and wherein ring A represents a 5 or 6 membered heteroring involvi

SPIRO COMPOUNDS AND METHODS FOR THE MODULATION OF CHEMOKINE RECEPTOR ACTIVITY

Compounds of formula I insert formula I from claim 1 wherein X, Y, Z, W, R1 and R2 as defined herein, or pharmaceutically acceptable salts, hydrates or solvates thereof, are useful for the modulation of CCR5 chemokine receptor activity.